คำอธิบาย
Fluconazole inhibits CYP3A4, which contributes to finasteride metabolism; co-administration may modestly increase finasteride plasma concentrations, though the clinical significance is generally low.
กลไก
Finasteride is metabolised primarily by CYP3A4; fluconazole's CYP3A4 inhibition reduces finasteride clearance, potentially increasing AUC by 10–20%; however, finasteride has a wide therapeutic index.
ความสำคัญทางคลินิก
No clinically significant adverse effects reported at usual doses; theoretical modest increase in finasteride side effects (sexual dysfunction) is unlikely to be detectable.
การจัดการ
No dose adjustment is required; monitor for increased finasteride side effects (decreased libido, erectile dysfunction) during prolonged fluconazole courses.
ข้อจำกัดความรับผิดชอบทางการแพทย์
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.